The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer
Z Kalaei, R Manafi-Farid, B Rashidi, FK Kiani… - Cell Communication and …, 2023 - Springer
The identification of contributing factors leading to the development of Colorectal Cancer
(CRC), as the third fatal malignancy, is crucial. Today, the tumor microenvironment has been …
(CRC), as the third fatal malignancy, is crucial. Today, the tumor microenvironment has been …
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
M Regmi, Y Wang, W Liu, Y Dai, S Liu, K Ma… - Journal of Experimental …, 2024 - Springer
In tumor therapeutics, the transition from conventional cytotoxic drugs to targeted molecular
therapies, such as those targeting receptor tyrosine kinases, has been pivotal. Despite this …
therapies, such as those targeting receptor tyrosine kinases, has been pivotal. Despite this …
Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: Preliminary data using a quantitative tool
Purpose The quantification of radiotherapy (RT)-induced functional and morphological brain
alterations is fundamental to guide therapeutic decisions in patients with brain tumors. The …
alterations is fundamental to guide therapeutic decisions in patients with brain tumors. The …
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma
Simple Summary Glioblastoma (GBM) is the deadliest primary central nervous system (CNS)
cancer in adults despite aggressive treatment. Once progressed, the prognosis is very poor …
cancer in adults despite aggressive treatment. Once progressed, the prognosis is very poor …
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
M Yang, M Cui, Y Sun, S Liu, W Jiang - Cell Communication and Signaling, 2024 - Springer
Anti-programmed death 1/programmed death ligand 1 (anti-PD-1/PD-L1) antibodies exert
significant antitumor effects by overcoming tumor cell immune evasion and reversing T-cell …
significant antitumor effects by overcoming tumor cell immune evasion and reversing T-cell …
Predictive value of procollagen c-protease enhancer protein on the prognosis of glioma patients
L Yu, X Hu, H Zhu - Heliyon, 2024 - cell.com
Procollagen c-protease enhancer protein (PCOLCE) performs an essential action in
improving the recreation of procollagen c-protease and promoting the reconstruction of …
improving the recreation of procollagen c-protease and promoting the reconstruction of …
Personalized Immunotherapy of Patients: Defining by Single-cell RNA-seq with Artificial Intelligence
B Li - Medical research archives, 2023 - esmed.org
Immunotherapy, including immune cell therapy and targeted therapy, is gradually developed
through the ongoing discovery of molecular compounds or immune cells. Choosing the best …
through the ongoing discovery of molecular compounds or immune cells. Choosing the best …
Genetyczne i molekularne podłoża rozwoju glejaka
P Panek, A Jezela-Stanek - Postępy Biochemii, 2023 - postepybiochemii.ptbioch.edu.pl
Glejak IV stopnia jest najczęściej diagnozowanym i jednocześnie najgorzej rokującym
nowotworem ośrodkowego układu nerwowego (OUN). Pacjenci chorujący na ten rodzaj …
nowotworem ośrodkowego układu nerwowego (OUN). Pacjenci chorujący na ten rodzaj …